46 results
8-K
EX-99.1
ITCI
Intra-Cellular Therapies Inc
10 Aug 20
Intra-cellular Therapies Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:52am
. “Real Progress” includes a national direct-to-consumer (or DTC) television advertising campaign and accompanying social media campaign, as well
8-K
EX-99.1
9vf6lby9poakz
23 Dec 19
FDA Approves Intra-Cellular Therapies’ Novel Antipsychotic, CAPLYTA® (lumateperone) for the Treatment of Schizophrenia in Adults
8:15am
8-K
EX-99.1
ndp98 e1g
2 Aug 18
Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2018 Financial Results
7:17am
8-K
EX-99.1
w44o3
6 Apr 16
Intra-Cellular Therapies Presents Additional ITI-007 Data at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference
12:00am
8-K
EX-99.3
kabi6vhv ow8wqz
6 Apr 16
Intra-Cellular Therapies Presents Additional ITI-007 Data at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference
12:00am